Primaquine pharmacokinetics in lactating women and breastfed infant exposures
Primaquine is the only drug providing radical cure of Plasmodium vivax malaria. It is not recommended for breastfeeding women as it causes hemolysis in glucose-6-phosphate dehydrogenase (G6PD) deficient individuals, and breast milk excretion and thus infant exposure are not known.Healthy G6PD normal...
Hoofdauteurs: | Gilder, M, Hanpithakphong, W, Hoglund, R, Tarning, J, Win, H, Hilda, N, Chu, C, Bancone, G, Carrara, V, Singhasivanon, P, White, N, Nosten, F, McGready, R |
---|---|
Formaat: | Journal article |
Taal: | English |
Gepubliceerd in: |
Oxford University Press
2018
|
Gelijkaardige items
-
Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants
door: Wattanakul, T, et al.
Gepubliceerd in: (2024) -
Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants
door: Thanaporn Wattanakul, et al.
Gepubliceerd in: (2024-05-01) -
Mechanistic modeling of primaquine pharmacokinetics, gametocytocidal activity, and mosquito infectivity
door: Chotsiri, P, et al.
Gepubliceerd in: (2022) -
Pharmacokinetic interactions between primaquine and chloroquine.
door: Pukrittayakamee, S, et al.
Gepubliceerd in: (2014) -
Antimalarial drugs for treating and preventing malaria in pregnant and lactating women
door: Saito, M, et al.
Gepubliceerd in: (2018)